000 01295 a2200385 4500
005 20250512054707.0
264 0 _c19870122
008 198701s 0 0 eng d
022 _a0271-9142
024 7 _a10.1007/BF00915254
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAllegretta, M
245 0 0 _aThe development of anti-interleukin-2 antibodies in patients treated with recombinant human interleukin-2 (IL-2).
_h[electronic resource]
260 _bJournal of clinical immunology
_cNov 1986
300 _a481-90 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntibody Formation
650 0 4 _aAntibody Specificity
650 0 4 _aCloning, Molecular
650 0 4 _aDrug Evaluation
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_ximmunology
650 0 4 _aLymphocyte Activation
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aNeutralization Tests
700 1 _aAtkins, M B
700 1 _aDempsey, R A
700 1 _aBradley, E C
700 1 _aKonrad, M W
700 1 _aChilds, A
700 1 _aWolfe, S N
700 1 _aMier, J W
773 0 _tJournal of clinical immunology
_gvol. 6
_gno. 6
_gp. 481-90
856 4 0 _uhttps://doi.org/10.1007/BF00915254
_zAvailable from publisher's website
999 _c3496822
_d3496822